FEFeng

Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests


Feng has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chuwen Li

    Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China

    1 shared publication
  • Jian-Nan Chen

    School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China

    1 shared publication
  • Sai-Xia Zhang

    School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, No. 232, Waihuandong Road, Guangzhou Higher Education Mega Center, Guangzhou 510006, China

    1 shared publication
  • Xiao-Jun Zhang

    School of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, PR China

    1 shared publication
  • Xiao-Ping Lai

    School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China

    1 shared publication
  • Xiaoli Wu

    The school of Biomedical and Pharmaceutical sciences, Guangdong University of Technology, Guangzhou 510006, China

    1 shared publication

Latest Publications

  • Open Access

    The Protective Effects of the Supercritical-Carbon Dioxide Fluid Extract ofChrysanthemum indicumagainst Lipopolysaccharide-Induced Acute Lung Injury in Mice via Modulating Toll-Like Receptor 4 Signaling Pathway

    by Xiao-Li Wu, Xue-Xuan Feng, Chu-Wen Li, Xiao-Jun Zhang, Zhi-Wei Chen, Jian-Nan Chen, Xiao-Ping Lai, Sai-Xia Zhang, Yu-Cui Li, Zi-Ren Su

    The supercritical-carbon dioxide fluid extract ofChrysanthemum indicumLinné. (CFE) has been demonstrated to be effective in suppressing inflammation. The aim of this study is to investigate the preventive action and underlying mechanisms of CFE on acute lung injury (ALI) induced by lipopolysaccharide (LPS) in mice. ALI was induced by intratracheal instillation of LPS into lung, and dexamethasone was used as a positive control. Results revealed that pretreatment with CFE abated LPS-induced lung histopathologic changes, reduced the wet/dry ratio and proinflammatory cytokines productions (TNF-α, IL-1β, and IL-6), inhibited inflammatory cells migrations and protein leakages, suppressed the levels of MPO and MDA, and upregulated the abilities of antioxidative enzymes (SOD, CAT, and GPx). Furthermore, the pretreatment with CFE downregulated the activations of NF-κB and the expressions of TLR4/MyD88. These results suggested that CFE exerted potential protective effects against LPS-induced ALI in mice and was a potential therapeutic drug for ALI. Its mechanisms were at least partially associated with the modulations of TLR4 signaling pathways.